276 related articles for article (PubMed ID: 10820524)
1. HPV primary screening for cervical cancer: more pain than protection.
Davey DD; Armenti CA
Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
[No Abstract] [Full Text] [Related]
2. HPV testing in cervical screening.
Cuzick J
Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
[No Abstract] [Full Text] [Related]
3. Forgotten implications of HPV positivity for the majority of females: a clinical perspective.
Tidy J
Cytopathology; 2002 Oct; 13(5):263-6. PubMed ID: 12421441
[No Abstract] [Full Text] [Related]
4. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
5. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus DNA detection for cervical cancer screening.
Press RD
Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
[No Abstract] [Full Text] [Related]
7. [Papillomavirus screening: shall it be performed systematically?].
Agius G; Beby-Defaux A
Transfus Clin Biol; 2003 Apr; 10(2):86-9. PubMed ID: 12763151
[No Abstract] [Full Text] [Related]
8. Time to consider HPV testing in cervical screening.
Cuzick J
Ann Oncol; 2001 Nov; 12(11):1511-4. PubMed ID: 11822748
[No Abstract] [Full Text] [Related]
9. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
Franco EL
J Natl Cancer Inst; 2009 Dec; 101(23):1600-1. PubMed ID: 19903806
[No Abstract] [Full Text] [Related]
10. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
12. Could HPV testing become the sole primary cervical screening test?
Sasieni P; Cuzick J
J Med Screen; 2002; 9(2):49-51. PubMed ID: 12133918
[No Abstract] [Full Text] [Related]
13. HPV testing is not useful for LSIL Triage--but stay tuned.
Stoler MH
Adv Anat Pathol; 2001 May; 8(3):160-4. PubMed ID: 11345239
[No Abstract] [Full Text] [Related]
14. Role of HPV-assay as an adjuvant to Pap's smear for diagnosis of carcinoma cervix.
Shahi SK; Ranga S; Srivastava R
Indian J Pathol Microbiol; 2000 Oct; 43(4):383-5. PubMed ID: 11344599
[No Abstract] [Full Text] [Related]
15. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
[TBL] [Abstract][Full Text] [Related]
16. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Wright TC
Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S239-46. PubMed ID: 17161163
[No Abstract] [Full Text] [Related]
17. Benefits and costs of using HPV testing to screen for cervical cancer.
Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
[TBL] [Abstract][Full Text] [Related]
18. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.
Coste J; Cochand-Priollet B; de Cremoux P; Le Galès C; Cartier I; Molinié V; Labbé S; Vacher-Lavenu MC; Vielh P;
BMJ; 2003 Apr; 326(7392):733. PubMed ID: 12676841
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
Kim JJ; Wright TC; Goldie SJ
JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
[TBL] [Abstract][Full Text] [Related]
20. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]